December 15, 2021 | I24NEWS i24NEWSDecember 15, 2021, 08:58 PM latest revision December 15, 2021, 08:59 PM i24NEWSAnchor Jeff Smith (R) and Dr. Dadi Segal, Panaxia
December 8, 2021 | BENZINGA Medical cannabis producer Panaxia Labs Israel Ltd. (TASE: PNAX), a subsidiary of Panaxia Global (TASE: PNAX) and Neuraxpharm, a European company that specializes in the central nervous system have launched sales
November 29, 2021 | Yahoo! The company resumed double-digit growth following a decrease in Q2 due to divesting its distribution and logistics operations. Revenues in the
November 3, 2021 | Yahoo! This week, the first export of medical cannabis extracts for inhalation left Israel to Germany, the largest and fastest-growing medical cannabis
September 2, 2021 | Yahoo! In the cumulative first six months of 2021, the company executed retail sales in Germany and Cyprus; Revenues of the 2nd
August 19, 2021 | Yahoo! The companies signed an agreement for the distribution of advanced medical cannabis-based products in Poland. First sales are expected during H1
July 29, 2021 | MarketWatch TEL AVIV, Israel and BIELEFELD, Germany, July 29, 2021 /PRNewswire via COMTEX/ — TEL AVIV, Israel and BIELEFELD, Germany, July 29,
June 21 2021 | Benzinga by Jelena Martinovic Israel’s largest manufacturer and home-delivery distributor of medical cannabis products, Panaxia Labs Israel Ltd., and its German partner Neuraxpharm received the green
May 31 2021 | Yahoo! 62% growth over the corresponding period the previous year and 16% over the previous quarter; The company is currently focused on
May 19 2021 | Yahoo! Following a successful launch at the local markets in Germany, France, and Cyprus, Panaxia’s medical cannabis-based products will be distributed in